Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoko Ito

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|January 20, 2023
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapiesDaisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, et al.
Leukemia & Lymphoma|February 14, 2022
Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantationTakashi Nagayama, Shin-Ichiro Fujiwara, Tomohiro Kikuchi, et al.
Blood Advances|November 8, 2019
Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuationChihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda, et al.
International Journal of Hematology|November 30, 2017
Successful treatment of follicular lymphoma with second-generation tyrosine kinase inhibitors administered for coexisting chronic myeloid leukemiaShin-Ichiro Fujiwara, Yuya Shirato, Takashi Ikeda, et al.
Blood|May 17, 2022
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myelomaChihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama, et al.
Transplantation and Cellular Therapy|October 6, 2023
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple MyelomaChihiro Yamamoto, Daisuke Minakata, Daizo Yokoyama, et al.
Annals of Hematology|November 27, 2018
Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasiaKiyomi Mashima, Takashi Ikeda, Shin-Ichiro Kawaguchi, et al.
International Journal of Hematology|December 12, 2018
Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignanciesDaisuke Minakata, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Acta Haematologica|February 26, 2019
TAFRO Syndrome with an Anterior Mediastinal Mass and Lethal Autoantibody-Mediated Thrombocytopenia: An Autopsy Case ReportKaoru Morita, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Acta Haematologica|August 29, 2019
Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective AnalysisDaisuke Minakata, Shin-Ichiro Fujiwara, Jin Hayakawa, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|January 20, 2023
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapiesDaisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, et al.
Leukemia & Lymphoma|February 14, 2022
Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantationTakashi Nagayama, Shin-Ichiro Fujiwara, Tomohiro Kikuchi, et al.
Blood Advances|November 8, 2019
Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuationChihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda, et al.
International Journal of Hematology|November 30, 2017
Successful treatment of follicular lymphoma with second-generation tyrosine kinase inhibitors administered for coexisting chronic myeloid leukemiaShin-Ichiro Fujiwara, Yuya Shirato, Takashi Ikeda, et al.
Blood|May 17, 2022
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myelomaChihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama, et al.
Transplantation and Cellular Therapy|October 6, 2023
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple MyelomaChihiro Yamamoto, Daisuke Minakata, Daizo Yokoyama, et al.
Annals of Hematology|November 27, 2018
Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasiaKiyomi Mashima, Takashi Ikeda, Shin-Ichiro Kawaguchi, et al.
International Journal of Hematology|December 12, 2018
Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignanciesDaisuke Minakata, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Acta Haematologica|February 26, 2019
TAFRO Syndrome with an Anterior Mediastinal Mass and Lethal Autoantibody-Mediated Thrombocytopenia: An Autopsy Case ReportKaoru Morita, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Acta Haematologica|August 29, 2019
Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective AnalysisDaisuke Minakata, Shin-Ichiro Fujiwara, Jin Hayakawa, et al.
Pageof 9